Published in Lab Business Week, March 11th, 2007
Commenting on the momentous occasion, Malvinder Mohan Singh, CEO & Managing Director, Ranbaxy, said, "The introduction of Atorvastatin in Denmark is a significant milestone in Ranbaxy's Atorvastatin strategy and heralds the beginning of the Company's determined efforts to bring affordable Atorvastatin to patients in Europe and other parts of the world." He further added, "Generic Atorvastatin will bring significant and immediate cost benefits to the Danish healthcare system."
The Company will continue to actively pursue all options in the EU and other markets...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.